Palatin Technologies Inc (PTN)
2.035
+0.16
(+8.82%)
USD |
NYAM |
May 02, 16:00
2.035
0.00 (0.00%)
After-Hours: 19:19
Palatin Technologies Cash from Financing (Quarterly): 4.974M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.974M |
| September 30, 2023 | 0.4489M |
| June 30, 2023 | 1.008M |
| March 31, 2023 | -0.8777M |
| December 31, 2022 | 9.790M |
| September 30, 2022 | -0.0247M |
| June 30, 2022 | -0.0244M |
| March 31, 2022 | -0.0371M |
| December 31, 2021 | 0.2823M |
| September 30, 2021 | -0.2024M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.0046M |
| December 31, 2020 | -0.0113M |
| September 30, 2020 | -0.0778M |
| June 30, 2020 | -0.0186M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.3164M |
| September 30, 2019 | -1.587M |
| June 30, 2019 | 30.64M |
| March 31, 2019 | -1.00M |
| December 31, 2018 | -2.470M |
| September 30, 2018 | 0.1565M |
| June 30, 2018 | 1.783M |
| March 31, 2018 | -1.990M |
| December 31, 2017 | -2.007M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.917M |
| June 30, 2017 | -1.960M |
| March 31, 2017 | -1.559M |
| December 31, 2016 | 14.38M |
| September 30, 2016 | 7.464M |
| June 30, 2016 | -0.065M |
| March 31, 2016 | -0.0065M |
| December 31, 2015 | -0.0972M |
| September 30, 2015 | 29.64M |
| June 30, 2015 | 0.0409M |
| March 31, 2015 | -0.6561M |
| December 31, 2014 | 29.21M |
| September 30, 2014 | -0.1221M |
| June 30, 2014 | -0.0132M |
| March 31, 2014 | 0.0314M |
| December 31, 2013 | -0.006M |
| September 30, 2013 | -0.0311M |
| June 30, 2013 | -0.0584M |
| March 31, 2013 | -0.0056M |
| December 31, 2012 | -0.0102M |
| September 30, 2012 | 34.37M |
| June 30, 2012 | -0.0053M |
| March 31, 2012 | -0.0089M |
| December 31, 2011 | -0.0105M |
| September 30, 2011 | -0.0103M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.587M
Minimum
Sep 2019
30.64M
Maximum
Jun 2019
2.314M
Average
-0.0113M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Oragenics Inc | -0.1806M |
| Outset Medical Inc | 33.23M |
| Ligand Pharmaceuticals Inc | 5.315M |
| Galectin Therapeutics Inc | 10.00M |
| ADMA Biologics Inc | -38.99M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.48M |
| Cash from Investing (Quarterly) | 9.462M |
| Free Cash Flow | -26.75M |
| Free Cash Flow Per Share (Quarterly) | -0.7457 |
| Free Cash Flow to Equity (Quarterly) | -10.51M |
| Free Cash Flow to Firm (Quarterly) | -10.51M |
| Free Cash Flow Yield | -106.4% |